NICOLE BOWAN: Open Payments
NPI 1295731693 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 48 payments from 12 companies in 2025. Trend: 2023 $858 · 2024 $1,424 · 2025 $1,240
Food & beverage: $1,240
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $451 |
| ABBVIE INC. | 11 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $133 |
| Phathom Pharmaceuticals, Inc. | 6 | $114 |
| Janssen Scientific Affairs, LLC | 1 | $103 |
| Madrigal Pharmaceuticals | 1 | $91 |
| Ardelyx, Inc. | 3 | $55 |
| Novo Nordisk Inc | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Celltrion USA Inc. | 1 | $25 |
Products named: TREMFYA, VOQUEZNA, REZDIFFRA, ENTYVIO, SKYRIZI, CREON, IBSRELA, DUPIXENT.
Industry payments across PA — which companies pay providers there.
